Table 3 The detailed resistance rate (%) of Staphylococcus aureus during 2022Q1 to 2023Q2
Antimicrobial | 2022Q1 (n = 22) | 2022Q2 (n = 17) | 2022Q3 (n = 15) | 2022Q4 (n = 20) | 2023Q1 (n = 23) | 2023Q2 (n = 22) |
|---|---|---|---|---|---|---|
Resistance rate (%) | Resistance rate (%) | Resistance rate (%) | Resistance rate (%) | Resistance rate (%) | Resistance rate (%) | |
Amikacin (loanword) | 0 | 0 | 0 | 0 | 0 | 0 |
Azithromycin (macrolide antibiotic) | 71.4 | 52.9 | 60 | 63.2 | 82.6 | 59.1 |
Benzazoline (antifungal agent) | 36.4 | 5.9 | 13.3 | 45 | 43.5 | 22.7 |
Cotrimoxazole | 13.6 | 11.8 | 0 | 0 | 0 | 0 |
Erythromycin (antibiotic) | 71.4 | 58.8 | 60 | 63.2 | 82.6 | 59.1 |
Clarithromycin (antibiotic) | 71.4 | 52.9 | 60 | 63.2 | 82.6 | 59.1 |
Clindamycin | 61.9 | 29.4 | 53.3 | 47.4 | 65.2 | 13.6 |
Rifampicin (loanword) | 0 | 0 | 0 | 0 | 0 | 0 |
Linezolid | 0 | 0 | 0 | 0 | 0 | 0 |
Chloromycetin | 0 | 0 | 0 | 5.3 | 0 | 0 |
Moxifloxacin | 0 | 0 | 0 | 0 | 0 | 9.1 |
Penicillin (antibiotic) | 100 | 88.2 | 100 | 100 | 91.3 | 100 |
Gentamycin (antibiotic) | 0 | 0 | 0 | 5 | 8.7 | 9.1 |
Tetracycline | 13.6 | 0 | 0 | 30 | 8.7 | 13.6 |
Tigecycline (antibiotic) | 0 | 0 | 0 | 0 | 0 | 0 |
Ticoranin | 0 | 0 | 0 | 10 | 0 | 0 |
Furantoin | 0 | |||||
Norfloxacin | 12.5 | 0 | 13.3 | 0 | 43.5 | 22.7 |
Vancomycin (antibiotic) | 0 | 0 | 0 | 0 | 0 | 0 |
Levofloxacin | 4.5 | 5.9 | 0 | 5 | 13 | 18.2 |